Biểu đồ giá cổ phiếu PASG
PASG Giá
Passage Bio Inc
$4.21
3.18%
$0.12
Khi đóng cửa: May 08, 16:00:00 GMT-4
$4.36
3.56%
$0.15
Phiên sau giờ: May 08, 20:00:00 GMT-4
Quay lại
Passage Bio Inc (PASG) Giá
Thống kê chính
Giá đóng cửa trước
$4.08
Giá mở cửa
$4.13
Phạm vi ngày
$3.93 - $4.36
Phạm vi 52 tuần
$4.36 - $20
Khối lượng
105.8K
Khối lượng trung bình
67.0K
Tỷ suất cổ tức
--
EPS (TTM)
-14.44
Vốn hóa thị trường
$13.9M
PASG là gì?
Passage Bio, Inc. operates as a genetic medicines company. The company is headquartered in Philadelphia, Pennsylvania and currently employs 24 full-time employees. The company went IPO on 2020-02-28. Its lead clinical product candidate, PBFT02, seeks to elevate progranulin levels to enhance lysosomal function and slow disease progression across a variety of neurodegenerative diseases. PBFT02 utilizes an adeno-associated virus serotype 1, or AAV1, capsid to deliver a functional granulin gene, encoding progranulin (PGRN), to the brain via intra cisterna magna (ICM) administration. Its development programs consist of PBFT02 for the treatment of FTD-GRN, PBFT02 for the treatment of FTD-C9orf72 and amyotrophic lateral sclerosis, and PBFT02 for the treatment of Alzheimer’s disease. Its clinical product candidates include PBGM01, PBKR03 and PBML04. The company has one unnamed preclinical research program that explores multiple potential treatment targets for Huntington's disease.
